Top Stories

This year's holiday shopping season has got off to a strong start. Online shoppers spent $1.52 billion on Thanksgiving Day, with smartphones accounting for 46 percent of all traffic to U.S. retail websites, according to Adobe Analytics data. The $1.52...


Germany's business confidence strengthened to a new record in November on optimistic expectations, suggesting another strong quarter for the economy. The business climate index rose to 117.5 in November from a revised 116.8 in October, survey data...


President Donald Trump is scheduled to meet with congressional leaders next week to discuss legislative issues, including a potential agreement to avoid a government shutdown. Trump is due to hold talks with House Speaker Paul Ryan, R-Wis., House Minority...


Following the Thanksgiving Day holiday on Thursday, stocks saw modest strength in an abbreviated trading session on Friday. With the upward move on the day, the tech-heavy Nasdaq and the S&P 500 reached new record closing highs.


Uma Thurman has finally responded against Harvey Weinstein, who is mired in multiple sex scandals, by saying the disgraced Hollywood film tycoon does not "deserve a bullet". The acclaimed American actress, model and activist vented her anger in a Thanksgiving...

Pharma-111417.jpg Shares of Catalyst Pharmaceuticals Inc. (CPRX) are up an impressive 179% year-to-date while the iShares NASDAQ Biotechnology Index ETF (IBB) has gained just 17% during the same period.
volkswagen-112017.jpg Volkswagen plans to invest about 22.8 billion euros in its core brand from 2018 to 2022, with main focus on e-mobility and modularization. In a statement on Saturday, the German automaker announced that the investments, as part of the brand's Transform 2025+ strategy, will significantly boost the brand's largest product and technology offensive.
ThailandGDP-112017.jpg Thailand's economy grew at the fastest pace in more than four years in the third quarter, largely driven by foreign demand and tourism. Gross domestic product expanded 4.3 percent year-on-year, bigger than the revised 3.8 percent growth posted a quarter ago, data from the National Economic and Social Development Board showed Monday.
sharelower-112017.jpg European stocks look set to open lower on Monday amid U.S. tax reform uncertainty and a political impasse in Germany after preliminary coalition talks collapsed. Gold prices dipped and the dollar held close to a one-month high hit in the previous...
DonaldTrump-Speech1-112417.jpg President Donald Trump is scheduled to meet with congressional leaders next week to discuss legislative issues, including a potential agreement to avoid a government shutdown. Trump is due to hold talks with House Speaker Paul Ryan, R-Wis., House Minority...
AlFranken-112417.jpg Amid new allegations of inappropriate touching, Senator Al Franken, D-Minn., issued an apology Thursday for making "some women feel badly." "I'm a warm person; I hug people. I've learned from recent stories that in some of those encounters, I crossed a line for some women — and I know that any number is too many," Franken said.
Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.
Canadian stocks edged higher in thin trade Friday, tuching fresh record highs on a rally in crude oil prices. With U.S. markets closed early as part of the Thanksgiving holiday, the TSX Composite Index rose 29.78 points to 16,104.08 on light volume. Aurora Cannabis Inc. (ACB.TO) has formally commenced...
Shares of thyssenKrupp AG were gaining around 2 percent in the morning trading in Germany after the steel giant Thursday said it expects clearly positive net income and significantly higher adjusted EBIT, a key earnings metric, in fiscal 2018. This was after reporting higher adjusted EBIT, sales and order intake in its fiscal 2017, despite a net loss due to charges.
Today's Daily Dose brings you news about FDA approval of the first 2-drug regimen for HIV; share repurchase by SunLink Health; promising early observations from DelMar's phase II trial of VAL-083 in glioblastoma; Starpharma's progress in Bacterial Vaginosis trial and Ardelyx's pipeline update. More
Shares of Medicrea Group climbed around 31 percent in the morning trading in Paris after the French medical devices company announced Wednesday that it has received Food and Drug Administration or FDA clearance for its IB3D range of 3D-printed Titanium... More
Zimbabwe's leader Robert Mugabe has vowed to stay in power for several weeks, despite intensifying pressure on him to stand down, according to reports. In a live TV address, Mr Mugabe said he would preside over the ruling party's congress in December. The...
Uber-Hack-112217.jpg Uber is facing government scrutiny after its disclosure that the ride-hailing company concealed a massive security breach, where hackers accessed the personal information of 57 million riders and drivers last year. As per reports, Uber paid $100,000 to hackers to hide the breach from public.
Follow RTT
Economic Calendar
11/24/17 10:0Current Account Balance - BoPQ3 Mexico
11/24/17 10:0Capital Account Balance - BoPQ3 Mexico
11/24/17 9:45PMI ManufacturingNOV P United States
11/24/17 9:45PMI CompositeNOV P United States
11/24/17 9:45PMI ServicesNOV P United States
11/24/17 9:0GDP (Q-o-Q)Q3 SA Mexico
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/23/18RHHBYEmicizumab (BLA)FDA decision on Emicizumab for haemophilia A with inhibitors
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
01/24/18SGYPTRULANCE (sNDA)FDA decision on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation
01/12/18LGNDLUXTURNA (BLA)FDA decision on LUXTURNA for inherited retinal disease
01/12/18ONCELUXTURNA (BLA)FDA decision on LUXTURNA for treatment of patients with vision loss due to confirmed biallelic RPE65 mutation-associated retinal dystrophy.
Complete FDA Calendar